<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02931266</url>
  </required_header>
  <id_info>
    <org_study_id>1102</org_study_id>
    <nct_id>NCT02931266</nct_id>
  </id_info>
  <brief_title>PASS MIS® Post-market Clinical Follow-up</brief_title>
  <official_title>Evaluation of the Efficacy and Safety of the PASS MIS® System in the Treatment of Spinal Thoracolumbar Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicrea International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicrea International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multicenter non comparative and observational study (post-market clinical&#xD;
      follow-up).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients operated with PASS MIS® manufactured by MEDICREA® INTERNATIONAL between July 2016&#xD;
      and July 2017.&#xD;
&#xD;
      The inclusion period will be 12 months and the follow-up 24 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Spinal stability</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>To evaluate though X-rays, the efficacy of the device to promote the stability of the instrumented segments.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spinal fusion</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>Radiological assessment of bony fusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>During surgery, 1-6 months, 12 months, 24 months postoperatively</time_frame>
    <description>To quantify and describe adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability</measure>
    <time_frame>1-6 months, 12 months, 24 months postoperatively</time_frame>
    <description>To assess patients' disability through ODI questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction index</measure>
    <time_frame>1-6 months, 12 months, 24 months postoperatively</time_frame>
    <description>To assess patient satisfaction after surgery using a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>1-6 months, 12 months, 24 months postoperatively</time_frame>
    <description>To assess patient's pain using visual analogue scale</description>
  </secondary_outcome>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Spinal Fractures</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PASS MIS®</intervention_name>
    <description>Posterior mini-invasive osteosynthesis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient suffering from thoraco-lumbar spinal fracture and receiving a posterior&#xD;
        osteosynthesis through a mini-invasive approach&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient which need to be operated to treat a fracture at the lumbar and/or thoracic&#xD;
             spine with the PASS MIS® device from MEDICREA®&#xD;
&#xD;
          -  Patient &gt; 18years&#xD;
&#xD;
          -  Patient with a mature skeleton&#xD;
&#xD;
          -  Patient able to understand the protocol and the planning visit&#xD;
&#xD;
          -  Patient able to complete a self-administered questionnaire&#xD;
&#xD;
          -  Patient who have signed the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient presenting other medical indication than thoracolumbar fracture&#xD;
&#xD;
          -  Patient unable or who refuse to sign an informed consent form&#xD;
&#xD;
          -  Patient unable to complete a self-administered questionnaire&#xD;
&#xD;
          -  Patient judged as non-compliant by the investigator or not able to come back for&#xD;
             follow-up visits&#xD;
&#xD;
          -  Patient who need to receive or who received an open procedure&#xD;
&#xD;
          -  Patient who has been not implanted with the PASS MIS® system&#xD;
&#xD;
          -  Pregnant women or intending to get pregnant within the next 2 years after the surgery&#xD;
&#xD;
          -  Patient with contra-indications to do radiographies&#xD;
&#xD;
          -  Local infectious state&#xD;
&#xD;
          -  Allergy or intolerance to the materials, suspected or known&#xD;
&#xD;
          -  Any contra-indications present in the notice of the product&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephane Fuentes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital la Timone, Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Estelle Douceron, PhD</last_name>
    <email>clinicalstudy@medicrea.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Fuentes, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Benjamin Blondel, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>October 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

